Independent

[flipper44]

Strangely, three months after Mimivax announced its one and only interim analysis had been conducted on the Survaxm 2b trial, Roswell announced it again/anew as if it never happened three months earlier.

Strangely, the second announcement would have more accurately fit the timeline previously predicted by the principle investigator on December 17, 2024 that the 50% event accrual should be hit in several months from then. It wasn’t, it was hit much sooner, probably only one month.

1. February 12, 2025, Mimivax announces it completed its interim analysis of the Survaxm 2b trial(which was triggered by 50% death events.) https://www.mimivax.com/mimivax-survaxm-interim-analysis/

2. May 8, 2025, Roswell Park Comprehensive Cancer Center makes the same announcement about Survaxm as if the first announcement never happened. https://www.roswellpark.org/newsroom/202505-roswell-park-announces-positive-progress-clinical-trial-novel-immunotherapy-survaxm

That’s not OK.